The Association of Ponderal Benznidazole with its Ultra-high Diluted Formula Reduces the Toxic Effects and Allows Increasing of Dose in Dose-dependent Protocol in Mice Infected with Trypanosoma cruzi

Aleixo, Denise Lessa; Benvenutti, Mateus Joacir; Lera, Katiucha Rebeca Jennifer Lopes; Ciupa, Larissa; Ferraz, Fabiana Nabarro; Araújo, Silvana Marques de.
Int. j. high dilution res ; 14(3): 10-19, 2015.
Artigo em Inglês | LILACS | ID: lil-783288

Documentos relacionados

  1. The Association of Ponderal Benznidazole with its Ultra-high Diluted Formula Reduces the Toxic Effects and Allows Increasing of Dose in Dose-dependent Protocol in Mice Infected with Trypanosoma cruzi
  2. Trypanosoma cruzi: Does the intake of nanoencapsulated benznidazole control acute infections?
  3. Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice.
  4. Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates.
  5. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>.
  6. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  7. Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells.
  8. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.
  9. Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia.
  10. Effectiveness of the repurposed drug isotretinoin in an experimental murine model of Chagas disease.